Ultragenyx Pharma (RARE) PT Lowered to $18 at Wells Fargo, Downgrades to Equalweight

September 3, 2026 5:49 AM

Wells Fargo analyst Ben Burnett lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $18.00 (from $50.00) while downgrading ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found